Publication Cover
Progress in Palliative Care
Science and the Art of Caring
Volume 12, 2004 - Issue 4
10
Views
0
CrossRef citations to date
0
Altmetric
Review Article

HAART in AIDS dementia complex and palliative care

Pages 171-177 | Published online: 19 Jul 2013

  • McArthur JC, Hoover DR, Bacellar H, Cohen BA, Becker JT et al. Dementia in AIDS patients: incidence and risk factors. Neurology 1993;43:2245–52.
  • Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003;17:1539–45.
  • Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999;13:1249–53.
  • Gonzalez E, Rovin BH, Sen L et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci USA 2002;99:13795–800.
  • Power C, McArthur JC, Nath A, Wehrly K, Mayne M, Nishio J et al. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol 1998;72):9045–53.
  • Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517–24.
  • Brew BJ. AIDS dementia complex. In: HIV Neurology. Oxford: Oxford University Press, 2001; 53–90.
  • Cysique LA, Bain M, Wright E, Maruff P, Brew BJ. Neuropsychological profile of AIDS dementia complex across pre-HAART and HAART eras. 16Th Annual Conference Australasian Society for HIV Medicine, September 2–4, Canberra, 2004.
  • McArthur JC, McDermott MP, McClernon D, St Hilliare C, Conant K, Marder K et al. Attenuated CNS infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 2004; In press.
  • Tozzi V. HIV dementia and minor cognitive motor disorders in the late HAART era. J Neurovirol 2004;10(Suppl 3):11.
  • Tozzi V, Balestra P, Galgani S, Narciso P, Sampaolesi A, Antinori A et al. Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr 2001;28:19–27.
  • Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004;18(Suppl 1):S75–8.
  • Cysique L, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW et al. Undetectable CSF HIV RNA and b-2 Microglobulin do not indicate inactive AIDS dementia complex. J AIDS 2004; In press.
  • Esiri MM, Biddolph SC, Morris CS. Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 1998;65:29–33.
  • Achim CL, Green DA, Avramut M, Schindelar J, Knight D, Masliah E. Axonal degeneration in the HIV brain. J Neurovirol 2004;10(Suppl 3):60.
  • Brew BJ, Pemberton L. Relationship between Alzheimer’s disease and AIDS dementia complex. 11th Conference on Retroviruses and Opportunistic Infections (CROI), San Francisco, February 8–11, 2004.
  • Friis-Moller N, Weber R, Reiss P, Yhiebaut R, Kirk O, d’Arminio Monforte T et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993–2003.
  • Gonzalez RG. Imaging NeuroAIDS. AJNR Am J Neuroradiol 2004;25:167–8.
  • Ernst T, Chang L, Leonido-Yee M, Speck O. Cerebral metabolites correlate with clinical severity of HIV cognitive-motor complex. Neurology 1999;52:100–8.
  • Brew BJ, Pemberton L, Cunningham P, Law M. Levels of HIV-1 RNA correlate with AIDS dementia. J Infect Dis 1997;175:963–6.
  • Brew BJ, Dunbar N, Pemberton L, Kaldor J. Cerebrospinal fluid concentrations of beta2 microglobulin and neopterin predict the development of AIDS dementia Complex. J Infect Dis 1996;174:294–8.
  • Ellis RJ, Moore DJ, Childers ME, Letendre S, McCutchan JA, Wolfson T et al. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol 2002;59:923–8.
  • Christensson B, Ljungberg B, Ryding E, Svenson G, Rosen I. SPECT with 99mTc-HMPAO in subjects with HIV infection: cognitive dysfunction correlates with high uptake. Scand J Infect Dis 1999;31:349–54.
  • Hinkin CH, van Gorp WG, Mandelkern MA, Gee M, Satz P, Holston S et al. Cerebral metabolic change in patients with AIDS: report of a six-month follow up using positron-emission tomography. Neuropsychiatry Clin Neurosci 1995;7:180–7.
  • Bencherif B, Rottenberg DA. Neuroimaging of the AIDS dementia complex. AIDS 1998;12:233–44.
  • Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S et al. Abacavir in AIDS dementia complex: efficacy and lessons for future trials. Neurology 2004; Under review.
  • Navia II Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986;19:525–35.
  • Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical- virological correlations. Ann Neurol 1995;38:563–70.
  • Anthony IC, Ramage S, Brannan FW, Bell JE. Premature neurodegeneration, inflammation and opiate misuse in HIV/AIDS before and after HAART. J Neurovirol 2004;10(Suppl 3):52.
  • Clements JE, Babas T, Mankowski JL, Suryanarayana K, Platak M Jr. Tarwater PM et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002;186:905–13.
  • Raivich G, Jones LL, Kloss CU, Werner A, Neumann H, Kreutzberg GW. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. Neuroscience 1998;18:5804–16.
  • Gartner S, Liu Y. Insights into the role of immune activation in HIV neuropathogenesis. J Neurovirol 2002;8):69–75.
  • Petito CK. Human immunodeficiency virus type 1 compartmentalization in the central nervous system. J Neurovirol 2004;10(Suppl 1):21–4.
  • Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;385:755–62.
  • Cysique LAJ, Maruff P, Brew BJ. Antiretroviral therapy in HIV-infection: are neurologically active drugs important? Arch Neurol 2004; In press.
  • Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK et al. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 2004;56:416–23.
  • Yilmaz A, Stahle L, Hagberg L, Svennerholm B, Fuchs D, Gisslen M. Cerebrospinal fluid HIV-1 RNA levels and drug concentrations following antiretroviral regimen with loponavir/ritonavir. J Neurovirol 2004;10(Suppl 3):89.
  • Cunningham P, Smith D, Satchell C, Cooper DA, Brew BJ. Evidence for independent development of reverse transcriptase inhibitor resistance patterns in the cerebrospinal fluid. AIDS 2000;14:1949–54.
  • Sacktor N, Schifitto G, McDermott MP, Marder K, McArthur JC, Kieburtz K. Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebocontrolled study. Neurology 2000;54:233–5.
  • Si Q, Cosenza M, Kim MO, Zhao ML, Brownlee M, Goldstein H et al. A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia. J Neurovirol 2004;10:284–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.